Search for: "United States v. Holman"
Results 41 - 60
of 66
Sorted by Relevance
|
Sort by Date
27 Jul 2009, 7:18 am
: Whirlpool Corporation v Kenwood Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (IPKat) EWHC (QB): When lawfully seized items can’t be retained under s 22 Police and Criminal Evidence Act 1984 (1709 Copyright Blog) United States US General Obama IP vacancies (IP Frontline) Kappos confirmation hearing set for 29 July (IP Watchdog) (IAM) (Peter… [read post]
22 Aug 2013, 4:00 am
Ltd. v. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
14 Dec 2007, 1:00 am
: (Holman), (IAM), Will Macrovision's acquisition of Gemstar result in a more aggressive IP Strategy in future? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
15 Dec 2020, 8:30 am
Bookstores, g., United States v. [read post]
15 Mar 2008, 7:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WIPO Copyright Committee 16th session to discuss Broadcast Treaty, new proposal for exceptions and limitations agreement: (Public Knowledge), (Public Knowledge), (Intellectual Property Watch), (Public Knowledge), (Public Knowledge), (IPwar’s), (Intellectual Property Watch), (KEI), (Public Knowledge), (IP Justice), (IP Justice), (KEI), (KEI),… [read post]
23 Dec 2007, 8:00 pm
: (IPEG),More on the implementation of the London Agreement and patent cost reduction in Europe: (Patent Baristas),ECJ rules that EU legislative obligations cannot be enforced in any Member State if that legislation has not been published in the Official Journal in the language of that Member State (Case C-161/06 OlomoucSkoma-Lux sro v Celni reditelstvi Olumouc): (IPKat),EPO fighting complex appl [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent… [read post]
16 Jul 2022, 1:00 am
In a recent decision of the Court of Protection, Re SB (A patient; capacity to consent to termination) [2013] EWHC 1417 (COP) 21 May 2013, Mr Justice Holman held that it had not been established that a woman, SB, undergoing treatment for bipolar disorder lacked capacity to make decisions about her desire to terminate her pregnancy and stated that he would either make a declaration to that effect or dismiss the proceedings. [read post]
30 Jul 2018, 10:44 am
(This is copyright, not patent, so I'll note it again tomorrow, but the rest of the panel is more patent-focused.)Lucas Osborn – 3D printing raises IP issues.Randy Picker – Reviews computer competition and innovation over last 100 years, including how WWII government contracting decisions shaped the computer patent environment.Michael Risch – 19th century apple-parer patents are instructive, including in showing how patent enforcement can channel innovation… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb),US: Dr Robert Shapiro discusses follow-on biologics report: (Patent Docs),US: New report identifies $387 billion in savings from generic biologics: (Holman's Biotech IP Blog),US: Can approval of biogenerics really save money? [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch) Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and then… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
30 Oct 2023, 8:51 am
Kelly v. [read post]
